Coronary heart disease
Conditions
Interventions
Group 1: Myocardial scintigraphy SPECT/CT
Sponsors
Universitätsklinikum Augsburg, Klinik für Nuklearmedizin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who are suspected of having chronic CHD after appropriate basic cardiological diagnostics and who have a corresponding pre-test probability. The range of indications for cardiac imaging diagnostics is considered to be a pre-test probability of CHD between 15 and 85% (average pre-test probability). The patient must be 18 years of age at the time of inclusion. Pregnancy is excluded by standard laboratory chemistry prior to the examination.
Exclusion criteria
Exclusion criteria: - Refusal of the clinical examination or participation in the study - Intolerance of the examination position due to other illnesses - Minors ( 200 mmHg syst., > 110 mmHg diast.) - Tachyarrhythmia or bradyarrhythmia - Hypertrophic cardiomyopathy and other forms of outflow tract obstruction - Severe AV blockages - Physical and/or psychological impairments - Ventricular pacemaker rhythm - Haemodynamically unstable patients or patients with acute myocardial infarction (ST segment elevation, Creatinine kinase or MB isoenzyme eleva
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of the study is to determine whether the CNN-based procedures for attenuation correction methods with the classical attenuation correction methods used in routine attenuation correction methods used in routine lead to methodological differences in the image data and ultimately also in the findings. | — |
Secondary
| Measure | Time frame |
|---|---|
| Furthermore, possible strengths and weaknesses of the individual strengths and weaknesses of the individual methods in order to determine whether one method is superior to the other. In addition, possible pitfalls in the diagnosis can be can be identified in order to further reduce the occurrence of false-positive or false-negative findings in the future. | — |
Countries
Germany
Contacts
Public ContactConstantin Lapa
Universitätsklinikum Augsburg, Klinik für Nuklearmedizin
Outcome results
None listed